Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis

American Heart Journal

Volumn 170, Issue 3, 2015, Pages 531-542.e1

  Salah, Khibar ^a   Pinto, Yigal M ^a   Eurlings, Luc W ^b   Metra, Marco ^c   Stienen, Susan ^a   Lombardi, Carlo ^c   Tijssen, Jan G ^a   Kok, Wouter E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; POTASSIUM; SODIUM; UREA; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CODING; POTASSIUM BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SODIUM BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; ACUTE DISEASE; BLOOD; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; EPIDEMIOLOGY; FOLLOW UP; HEART FAILURE; HYPOKALEMIA; ITALY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NETHERLANDS; PROSPECTIVE STUDY; SURVIVAL RATE; TIME; TRENDS; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOMARKERS; CAUSE OF DEATH; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPOKALEMIA; ITALY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NETHERLANDS; PEPTIDE FRAGMENTS; POTASSIUM; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84941735668     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.06.003     Document Type: Article

References (48)

1. J.G. Cleland, K. Swedberg, A. Cohen-Solal, and et al. The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York Eur J Heart Fail 2 2 2000 123 132
2. M.R. Cowie, A. Mosterd, D.A. Wood, and et al. The epidemiology of heart failure Eur Heart J 18 2 1997 208 225
3. K. Dickstein, A. Cohen-Solal, G. Filippatos, and et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 19 2008 2388 2442
4. G.A. Haldeman, J.B. Croft, W.H. Giles, and et al. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995 Am Heart J 137 2 1999 352 360
5. K.K. Ho, J.L. Pinsky, W.B. Kannel, and et al. The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 4 Suppl. A 1993 6A 13A
6. M. Gheorghiade, W.A. Gattis, C.M. O'Connor, and et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial JAMA 291 16 2004 1963 1971
7. M. Gheorghiade, F. Zannad, G. Sopko, and et al. Acute heart failure syndromes: current state and framework for future research Circulation 112 25 2005 3958 3968
8. F. Hartmann, M. Packer, A.J. Coats, and et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial Circulation 110 13 2004 1780 1786
9. A.S. Desai Hyperkalemia in patients with heart failure: incidence, prevalence, and management Curr Heart Fail Rep 6 4 2009 272 280
10. K. Salah, W.E. Kok, L.W. Eurlings, and et al. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score Heart 100 2 2014 115 125
11. L.W. Eurlings, P.E. van Pol, W.E. Kok, and et al. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study J Am Coll Cardiol 56 25 2010 2090 2100
12. M. Metra, S. Nordari, G. Parrinello, and et al. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T Eur J Heart Fail 9 8 2007 776 786
13. P.A. McKee, W.P. Castelli, P.M. McNamara, and et al. The natural history of congestive heart failure: the Framingham Study N Engl J Med 285 1971 1441 1446
14. K. Damman, T. Jaarsma, A.A. Voors, and et al. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH) Eur J Heart Fail 11 9 2009 847 854
15. M. Metra, S. Nodari, G. Parrinello, and et al. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance Eur J Heart Fail 10 2 2008 188 195
16. A. Ahmed, F. Zannad, T.E. Love, and et al. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure Eur Heart J 28 11 2007 1334 1343
17. C.B. Bowling, B. Pitt, M.I. Ahmed, and et al. Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies Circ Heart Fail 3 2 2010 253 260
18. S.S. Khan, U. Campia, O. Chioncel, and et al. Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial) Am J Cardiol 115 6 2015 790 796
19. J.E. Macdonald, and A.D. Struthers What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 43 2 2004 155 161
20. R. Agarwal, R. Afzalpurkar, and J.S. Fordtran Pathophysiology of potassium absorption and secretion by the human intestine Gastroenterology 107 2 1994 548 571
21. K.J. Sweadner, and S.M. Goldin Active transport of sodium and potassium ions: mechanism, function, and regulation N Engl J Med 302 14 1980 777 783
22. H.A. Cooper, D.L. Dries, C.E. Davis, and et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction Circulation 100 12 1999 1311 1315
23. G. Cotter, J. Weissgarten, E. Metzkor, and et al. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure Clin Pharmacol Ther 62 2 1997 187 193
24. L. Klein, C.M. O'Connor, J.D. Leimberger, and et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study Circulation 111 19 2005 2454 2460
25. J.M. McCurley, S.U. Hanlon, S.K. Wei, and et al. Furosemide and the progression of left ventricular dysfunction in experimental heart failure J Am Coll Cardiol 44 6 2004 1301 1307
26. D. Sica, R.M. Oren, M.D. Gottwald, and et al. Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction Clin Cardiol 33 6 2010 330 336
27. N. Girerd, P.S. Pang, K. Swedberg, and et al. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial Eur J Heart Fail 15 11 2013 1228 1235
28. M. Broqvist, U. Dahlstrom, B.E. Karlberg, and et al. Neuroendocrine response in acute heart failure and the influence of treatment Eur Heart J 10 12 1989 1075 1083
29. W. Johnson, T. Omland, C. Hall, and et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure J Am Coll Cardiol 39 10 2002 1623 1629
30. A.A. Van Vliet, A.J. Donker, J.J. Nauta, and et al. Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor Am J Cardiol 71 3 1993 21A 28A
31. J. Lakkis, W.X. Lu, and M.R. Weir RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease Curr Hypertens Rep 5 5 2003 408 417
32. A.D. Struthers Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure J Card Fail 2 1 1996 47 54
33. M. Cicoira, L. Zanolla, L. Franceschini, and et al. Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 89 4 2002 403 407
34. J.P. Ferreira, M. Santos, S. Almeida, and et al. Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure Eur J Intern Med 25 1 2014 67 72
35. B. Pitt, F. Zannad, W.J. Remme, and et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 10 1999 709 717
36. B. Pitt, G. Williams, W. Remme, and et al. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study Cardiovasc Drugs Ther 15 1 2001 79 87
37. F. Zannad, J.J. McMurray, H. Krum, and et al. Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 1 2011 11 21
38. J.H. Bauer, and W.C. Gauntner Effect of potassium chloride on plasma renin activity and plasma aldosterone during sodium restriction in normal man Kidney Int 15 3 1979 286 293
39. T.D. Smilde, D.J. van Veldhuisen, G. Navis, and et al. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction Circulation 114 15 2006 1572 1580
40. A.S. Levery, J.P. Bosch, J.B. Lewis, and et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
41. H.L. Hillege, D. Nitsch, M.A. Pfeffer, and et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure Circulation 113 2006 671 678
42. N.A. Khan, I. Ma, C.R. Thompson, and et al. Kidney function and mortality among patients with left ventricular systolic dysfunction J Am Soc Nephrol 17 2006 244 253
43. L. Klein, B.M. Massie, J.D. Leimberger, and et al. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Circ Heart Fail 1 2008 25 33
44. J.J. McMurray, S. Adamopoulos, S.D. Anker, and et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
45. G.C. Fonarow, K.F. Adams Jr., W.T. Abraham, and et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580
46. D. Lee, P.C. Austin, J.L. Rouleau, and et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of clinical model JAMA 290 2003 2581 2587
47. A. Bayés-Genís, L. Lopez, E. Zapico, and et al. NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality J Card Fail 11 2005 S3 S8
48. P. Bettencourt, A. Azevedo, J. Pimenta, and et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2004 2168 2174